Table 2. Human serological results, by gender and age group.
Variable | Category | Seronegative | Seropositive (seroprevalence [95% CI]) | Total |
---|---|---|---|---|
Gender | Male | 919 | 31 | 950 |
(3.3% [2.2%–4.6%]) | ||||
Female | 1078 | 21 | 1099 | |
(1.9% [1.2%–2.9%]) | ||||
Total | 1997 | 52 | 2049 | |
(2.5% [1.9%–3.3%]) | ||||
Age group | 5–14 years | 822 | 34 | 856 |
(4.0% [2.8%–5.5%]) | ||||
15–24 years | 363 | 8 | 371 | |
(2.2% [0.9%–4.2%]) | ||||
25 years + | 812 | 10 | 822 | |
(1.2% [0.6%–2.2%]) | ||||
Total | 1997 | 52 | 2049 | |
(2.5% [1.9%–3.3%]) |